Latigo Regulatory Monday, August 10, 2026 0.00 Neutral

Latigo Biotherapeutics amends certificate of incorporation

Latigo Biotherapeutics, Inc. amended its Certificate of Incorporation under Delaware law. The company increased its authorized Common Stock to 999,999,999 shares.

View original filing at SEC.gov →
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.

Get real-time financial news in your trading bot or app

GET FREE KEY — 10,000 calls/day